Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Monaco21on Sep 16, 2020 6:50pm

129 Views

Post# 31571871

RE:How explosive biotech stocks can get ....

Thank you for posting the article, elgin1. Very reassuring to read more about Trillium et al and how “have each generated enormous returns on capital for investors within an exceedingly short period of time”. Sernova could be the next Trillium. The science is there, the potential is similar and Trillium has a year-to-date growth of 1,260%!

Bullboard Posts

Options trading in a volatile macro environment